The authors review the regulatory changes associated with the use of dimethyl sulfoxide in finished pharmaceutical dosage forms.
Robert Strub
Advertisement
Robert Strub is director of business development at Gaylord Chemical Company LLC.
Articles by Robert Strub
The authors survey the approved applications of dimethyl sulfoxide USP, PhEur across the healthcare industry and consider the suitability of DMSO from a regulatory and formulation compatibility standpoint.
Advertisement
Latest Updated Articles
- Dimethyl Sulfoxide USP, PhEur in Approved Pharmaceutical Products and Medical Devices
Published: May 2nd 2008 | Updated:
Advances in the Regulated Pharmaceutical Use of Dimethyl Sulfoxide USP, Ph.Eur.Published: September 1st 2016 | Updated:
Advertisement
Advertisement
